| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A144510 from our risk checks.
GC Cell Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩37,850.00 |
| 52 Week High | ₩48,800.00 |
| 52 Week Low | ₩28,450.00 |
| Beta | 0.98 |
| 1 Month Change | -16.08% |
| 3 Month Change | -5.02% |
| 1 Year Change | -9.56% |
| 3 Year Change | -66.65% |
| 5 Year Change | -10.52% |
| Change since IPO | -21.31% |
Recent News & Updates
Recent updates
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative
Mar 19
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt
Feb 22Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?
Jan 18
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?
Dec 14Shareholder Returns
| A144510 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 5.9% | 4.1% | 0.5% |
| 1Y | -9.6% | 6.6% | 4.7% |
Return vs Industry: A144510 underperformed the KR Biotechs industry which returned 6.6% over the past year.
Return vs Market: A144510 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A144510 volatility | |
|---|---|
| A144510 Average Weekly Movement | 4.8% |
| Biotechs Industry Average Movement | 8.3% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A144510 has not had significant price volatility in the past 3 months.
Volatility Over Time: A144510's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 769 | James Park | www.gccell.com |
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021.
GC Cell Corporation Fundamentals Summary
| A144510 fundamental statistics | |
|---|---|
| Market cap | ₩568.61b |
| Earnings (TTM) | -₩174.01m |
| Revenue (TTM) | ₩187.54b |
3.0x
P/S Ratio-3,268x
P/E RatioIs A144510 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A144510 income statement (TTM) | |
|---|---|
| Revenue | ₩187.54b |
| Cost of Revenue | ₩132.41b |
| Gross Profit | ₩55.14b |
| Other Expenses | ₩55.31b |
| Earnings | -₩174.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -11.58 |
| Gross Margin | 29.40% |
| Net Profit Margin | -0.093% |
| Debt/Equity Ratio | 9.2% |
How did A144510 perform over the long term?
See historical performance and comparison